Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Gyre Therapeutics (GYRE) over the last 3 years, with Q3 2025 value amounting to $117000.0.

  • Gyre Therapeutics' Exchange Rate Effect rose 1037.74% to $117000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$39000.0, marking a year-over-year decrease of 11830.99%. This contributed to the annual value of -$273000.0 for FY2024, which is 838.93% up from last year.
  • Gyre Therapeutics' Exchange Rate Effect amounted to $117000.0 in Q3 2025, which was up 1037.74% from $49000.0 recorded in Q2 2025.
  • Gyre Therapeutics' Exchange Rate Effect's 5-year high stood at $231000.0 during Q4 2023, with a 5-year trough of -$900000.0 in Q2 2023.
  • For the 3-year period, Gyre Therapeutics' Exchange Rate Effect averaged around -$32272.7, with its median value being $50000.0 (2025).
  • As far as peak fluctuations go, Gyre Therapeutics' Exchange Rate Effect crashed by 21038.96% in 2024, and later surged by 20869.57% in 2025.
  • Gyre Therapeutics' Exchange Rate Effect (Quarter) stood at $231000.0 in 2023, then tumbled by 210.39% to -$255000.0 in 2024, then soared by 145.88% to $117000.0 in 2025.
  • Its Exchange Rate Effect stands at $117000.0 for Q3 2025, versus $49000.0 for Q2 2025 and $50000.0 for Q1 2025.